{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:07:34Z","timestamp":1791191254087,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1097\/tp.0000000000000592","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T13:14:07Z","timestamp":1421846047000},"page":"299-308","source":"Crossref","is-referenced-by-count":147,"title":["A Phase I\/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients"],"prefix":"10.1097","volume":"99","author":[{"given":"Ashley A.","family":"Vo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jua","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieko","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kahwaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Villicana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechu","family":"Puliyanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Reinsmoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches.","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"R2-18-20210129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R3-18-20210129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival.","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R4-18-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular jection of kidney allografts: a population-based study.","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"R5-18-20210129","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1172\/JCI72273","article-title":"Complement as a multifaceted modulator of kidney transplant injury.","volume":"124","author":"Cravedi","year":"2014","journal-title":"J Clin Invest"},{"key":"R6-18-20210129","first-page":"273","article-title":"Compstatin: a complement inhibitor on its way to clinical application.","volume":"632","author":"Ricklin","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"R8-18-20210129","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH Ig02 trial.","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R9-18-20210129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation.","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R10-18-20210129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival.","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R11-18-20210129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIGanti-Cd 20plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"R12-18-20210129","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R13-18-20210129","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"issue":"Supp 1","key":"R14-18-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00007890-201407151-00246","article-title":"Early subclincial alloantibody-associated injury in positive crossmatch kidney transplantation (XMKTx) despite terminal complement blockade.","volume":"98","author":"Dean","year":"2014","journal-title":"Transplantation"},{"key":"R15-18-20210129","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH10-01-0073","article-title":"C1 inhibitor, a multi-functional serine protease inhibitor.","volume":"104","author":"Davis","year":"2010","journal-title":"Thromb Haemost"},{"key":"R16-18-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2010.75","article-title":"Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons.","volume":"78","author":"Tillou","year":"2010","journal-title":"Kidney Int"},{"key":"R17-18-20210129","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab.","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"R18-18-20210129","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"R19-18-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituximab combined with IVIG for desensitization of renal transplant recipients.","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation"},{"key":"R20-18-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-6143.2007.02017.x","article-title":"Analysis of subcutaneous (Sq) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab.","volume":"8","author":"Vo","year":"2008","journal-title":"Am J Transplant"},{"key":"R21-18-20210129","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.2215\/CJN.03710411","article-title":"Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.","volume":"6","author":"Kahwaji","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-18-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R24-18-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MOT.0b013e328355fb9b","article-title":"New approaches for detecting complement-fixing antibodies.","volume":"17","author":"Tyan","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"R25-18-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients.","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R26-18-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R27-18-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/962702","article-title":"Complement diagnostics: concepts, indications, and practical guidelines.","volume":"2012","author":"Nilsson","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R28-18-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.295.2.199","article-title":"Does this patient have deep vein thrombosis","volume":"295","author":"Wells","year":"2006","journal-title":"JAMA"},{"key":"R29-18-20210129","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the united states: the long-term does not mirror the dramatic short-term success.","volume":"11","author":"Lodhi","year":"2011","journal-title":"Am J Transplant"},{"key":"R30-18-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","article-title":"Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period.","volume":"12","author":"Kohei","year":"2012","journal-title":"Am J Transplant"},{"key":"R31-18-20210129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/ajt.12308","article-title":"Cryptic B cell response to renal transplantation.","volume":"13","author":"Lynch","year":"2013","journal-title":"Am J Transplant"},{"key":"R32-18-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.20121525","article-title":"Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.","volume":"210","author":"Kwan","year":"2013","journal-title":"J Exp Med"},{"key":"R33-18-20210129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0805538","article-title":"Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.","volume":"363","author":"Zuraw","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-18-20210129","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/STROKEAHA.112.660340","article-title":"C1-Inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms.","volume":"43","author":"Heydenreich","year":"2012","journal-title":"Stroke"},{"key":"R35-18-20210129","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2353\/ajpath.2010.090276","article-title":"Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.","volume":"176","author":"Castellano","year":"2010","journal-title":"Am J Pathol"},{"key":"R36-18-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/SHK.0b013e31825a3522","article-title":"Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage.","volume":"38","author":"Dalle Lucca","year":"2012","journal-title":"Shock"},{"key":"R37-18-20210129","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.4049\/jimmunol.174.10.6462","article-title":"A direct role for C1 inhibitor in regulation of leukocyte adhesion.","volume":"174","author":"Cai","year":"2005","journal-title":"J Immunol"},{"key":"R38-18-20210129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/SHK.0b013e31825bf40e","article-title":"C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria.","volume":"38","author":"Mejia","year":"2012","journal-title":"Shock"},{"key":"R39-18-20210129","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/TP.0b013e3182845fe1","article-title":"Defining the benefits of desensitization therapy.","volume":"95","author":"Jordan","year":"2013","journal-title":"Transplantation"},{"key":"R40-18-20210129","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study.","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T06:43:25Z","timestamp":1690872205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201502150-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000592","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}